Biocept (BIOCQ) Stock Price
Biocept Price
Revenue has compounded at 72.6% per year over the past 10 years to 25.86 M USD. Biocept's net margin stands at -124.1%, up from -775.7% several years earlier.
Biocept stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Biocept business model & stock analysis
Frequently asked questions about Biocept
9 analysts currently rate the Biocept stock: 0 recommend buying, 4 holding and 5 selling.
Converted at the current exchange rate, the Biocept share trades at 0.00 EUR (0.00 USD).
The Biocept share (BIOCQ) is listed on 2 stock exchanges, including: NASDAQ (BIOC), Frankfurt (B00.F).
The revenue cannot currently be calculated for Biocept.
The profit cannot currently be calculated for Biocept.
The P/E ratio cannot be calculated for Biocept at the moment.
The P/S cannot be calculated for Biocept currently.
The Eulerpool Quality Score for Biocept is 4/10.
The ISIN of Biocept is US09072V6002. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Biocept is BIOCQ. The ticker symbol is used to trade Biocept shares on the stock exchange.
Biocept stock
Biocept Peer Group
Biocept Ticker
Biocept FIGI
All fundamentals and in-depth analysis of Biocept
Our stock analysis for Biocept stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biocept. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.